The expression of ferritin, lactoferrin, transferrin receptor and solute carrier family 11A1 in the host response to BCG-vaccination and Mycobacterium tuberculosis challenge

Vaccine

Volumn 30, Issue 21, 2012, Pages 3159-3168

  Thom, R E ^a   Elmore, M J ^a   Williams, A ^a   Andrews, S C ^b   Drobniewski, F ^c   Marsh, P D ^a   Tree, J A ^a  

^a Microbiological Services   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

BCG; Biomarkers; Ferritin; Guinea pig; Iron; Tuberculosis

Indexed keywords

BCG VACCINE; FERRITIN; LACTOFERRIN; MESSENGER RNA; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; NITRIC OXIDE; TRANSFERRIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; DOWN REGULATION; EX VIVO STUDY; FEMALE; GENE EXPRESSION PROFILING; GUINEA PIG; HEAVY CHAIN; IRON METABOLISM; LIGHT CHAIN; MICROARRAY ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; TUBERCULOSIS;

ANIMALS; BCG VACCINE; CATION TRANSPORT PROTEINS; FERRITINS; GENE EXPRESSION PROFILING; GUINEA PIGS; IRON; LACTOFERRIN; MICROARRAY ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, TRANSFERRIN; TUBERCULOSIS;

EID: 84859510786     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.03.008     Document Type: Article

References (45)

1. Harrison P.M., Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996, 1275(3):161-203.
2. Collins H.L. Withholding iron as a cellular defence mechanism-friend or foe?. Eur J Immunol 2008, 38(7):1803-1806.
3. Olakanmi O., Britigan B.E., Schlesinger L.S. Gallium disrupts iron metabolism of mycobacteria residing within human macrophages. Infect Immun 2000, 68(10):5619-5627.
4. Mainou-Fowler T., Brock J.H. Effect of iron deficiency on the response of mouse lymphocytes to concanavalin A: the importance of transferrin-bound iron. Immunology 1985, 54(2):325-332.
5. Trousseau A. Lectures on clinical medicine. Lecture LXXXVII; true and false chlorosis 1872, 3rd ed.
6. Walter T., Olivares M., Pizarro F., Munoz C. Iron, anemia, and infection. Nutr Rev 1997, 55(4):111-124.
7. Colditz G.A., Berkey C.S., Mosteller F., Brewer T.F., Wilson M.E., Burdick E., et al. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995, 96(1 Pt. 1):29-35.
8. Sander C., McShane H. Translational mini-review series on vaccines: development and evaluation of improved vaccines against tuberculosis. Clin Exp Immunol 2007, 147(3):401-411.
9. McMurray D.N., Collins F.M., Dannenberg A.M., Smith D.W. Pathogenesis of experimental tuberculosis in animal models. Curr Top Microbiol Immunol 1996, 215:157-179.
10. Williams A., Hall Y., Orme I.M. Evaluation of new vaccines for tuberculosis in the guinea pig model. Tuberculosis (Edinb) 2009, 89(6):389-397.
11. Tree J.A., Elmore M.J., Javed S., Williams A., Marsh P.D. Development of a guinea pig immune response-related microarray and its use to define the host response following Mycobacterium bovis BCG vaccination. Infect Immun 2006, 74(2):1436-1441.
12. Ohtani M., Kobayashi Y., Watanabe N. Gene expression in the elicitation phase of guinea pig DTH and CHS reactions. Cytokine 2004, 25(6):246-253.
13. Basaraba R.J., Bielefeldt-Ohmann H., Eschelbach E.K., Reisenhauer C., Tolnay A.E., Taraba L.C., et al. Increased expression of host iron-binding proteins precedes iron accumulation and calcification of primary lung lesions in experimental tuberculosis in the guinea pig. Tuberculosis (Edinb) 2008, 88(1):69-79.
14. Tree J.A., Williams A., Clark S., Hall G., Marsh P.D., Ivanyi J. Intranasal Bacille Calmette-Guerin (BCG) vaccine dosage needs balancing between protection and lung pathology. Clin Exp Immunol 2004, 138(3):405-409.
15. Lasco T.M., Yamamoto T., Yoshimura T., Allen S.S., Cassone L., McMurray D.N. Effect of Mycobacterium bovis BCG vaccination on Mycobacterium-specific cellular proliferation and tumor necrosis factor alpha production from distinct guinea pig leukocyte populations. Infect Immun 2003, 71(12):7035-7042.
16. James B.W., Williams A., Marsh P.D. The physiology and pathogenicity of Mycobacterium tuberculosis grown under controlled conditions in a defined medium. J Appl Microbiol 2000, 88(4):669-677.
17. Tree J.A., Patel J., Thom R.E., Elmore M.J., Schafer H., Williams A., et al. Temporal changes in the gene signatures of BCG-vaccinated guinea pigs in response to different mycobacterial antigens. Vaccine 2010, 28(50):7979-7986.
18. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., Bloom B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993, 178(6):2249-2254.
19. Volpe E., Cappelli G., Grassi M., Martino A., Serafino A., Colizzi V., et al. Gene expression profiling of human macrophages at late time of infection with Mycobacterium tuberculosis. Immunology 2006, 118(4):449-460.
20. McMurray D.N., Mintzer C.L., Bartow R.A., Parr R.L. Dietary protein deficiency and Mycobacterium bovis BCG affect interleukin-2 activity in experimental pulmonary tuberculosis. Infect Immun 1989, 57(9):2606-2611.
21. Klunner T., Bartels T., Vordermeier M., Burger R., Schafer H. Immune reactions of CD4- and CD8-positive T cell subpopulations in spleen and lymph nodes of guinea pigs after vaccination with bacillus Calmette-Guerin. Vaccine 2001, 19(15-16):1968-1977.
22. Yang D., Nakada-Tsukui K., Ohtani M., Goto R., Yoshimura T., Kobayashi Y., et al. Identification and cloning of genes associated with the guinea pig skin delayed-type hypersensitivity reaction. J Biochem (Tokyo) 2001, 129(4):561-568.
23. Jeevan A., Yoshimura T., Lee K.E., McMurray D.N. Differential expression of gamma interferon mRNA induced by attenuated and virulent Mycobacterium tuberculosis in guinea pig cells after Mycobacterium bovis BCG vaccination. Infect Immun 2003, 71(1):354-364.
24. Lim J., Derrick S.C., Kolibab K., Yang A.L., Porcelli S., Jacobs W.R., et al. Early pulmonary cytokine and chemokine responses in mice immunized with three different vaccines against Mycobacterium tuberculosis determined by PCR array. Clin Vaccine Immunol 2009, 16(1):122-126.
25. Mytar B., Woloszyn M., Ruggiero I., Pryjma J., Zembala M. Monocyte-mediated regulation of antigen-driven IFN gamma production by T cells. The role of endogenously produced TNF. Immunol Invest 1995, 24(6):897-906.
26. Byrd T.F., Horwitz M.A. Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes. Coordinate upregulation by iron transferrin and downregulation by interferon gamma. J Clin Invest 1993, 91(3):969-976.
27. Matthews J.R., Botting C.H., Panico M., Morris H.R., Hay R.T. Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res 1996, 24(12):2236-2242.
28. Weiss G., Goossen B., Doppler W., Fuchs D., Pantopoulos K., Werner-Felmayer G., et al. Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway. EMBO J 1993, 12(9):3651-3657.
29. Lee K.S., Lee D.K., Jeoung D., Lee H., Choe J., Ha K.S., et al. Differential effects of substrate-analogue inhibitors on nitric oxide synthase dimerization. Biochem Biophys Res Commun 2012, 418(1):49-55.
30. Flesch I.E., Kaufmann S.H. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect Immun 1991, 59(9):3213-3218.
31. Weinberg J.B., Misukonis M.A., Shami P.J., Mason S.N., Sauls D.L., Dittman W.A., et al. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 1995, 86(3):1184-1195.
32. Jeevan A., McFarland C.T., Yoshimura T., Skwor T., Cho H., Lasco T., et al. Production and characterization of guinea pig recombinant gamma interferon and its effect on macrophage activation. Infect Immun 2006, 74(1):213-224.
33. Harada T., Baba M., Torii I., Morikawa S. Ferritin selectively suppresses delayed-type hypersensitivity responses at induction or effector phase. Cell Immunol 1987, 109(1):75-88.
34. Zygmunt B.M., Rharbaoui F., Groebe L., Guzman C.A. Intranasal immunization promotes Th17 immune responses. J Immunol 2009, 183(11):6933-6938.
35. Kruzel M.L., Bacsi A., Choudhury B., Sur S., Boldogh I. Lactoferrin decreases pollen antigen-induced allergic airway inflammation in a murine model of asthma. Immunology 2006, 119(2):159-166.
36. Slater K., Fletcher J. Lactoferrin derived from neutrophils inhibits the mixed lymphocyte reaction. Blood 1987, 69(5):1328-1333.
37. Cumberbatch M., Bhushan M., Dearman R.J., Kimber I., Griffiths C.E. IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin. Clin Exp Immunol 2003, 132(2):352-359.
38. Olakanmi O., Schlesinger L.S., Britigan B.E. Hereditary hemochromatosis results in decreased iron acquisition and growth by Mycobacterium tuberculosis within human macrophages. J Leukoc Biol 2007, 81(1):195-204.
39. Jacobsen M., Repsilber D., Gutschmidt A., Neher A., Feldmann K., Mollenkopf H.J., et al. Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med 2007, 85(6):613-621.
40. Olakanmi O., Schlesinger L.S., Ahmed A., Britigan B.E. Intraphagosomal Mycobacterium tuberculosis acquires iron from both extracellular transferrin and intracellular iron pools. Impact of interferon-gamma and hemochromatosis. J Biol Chem 2002, 277(51):49727-49734.
41. Schaible U.E., Collins H.L., Priem F., Kaufmann S.H. Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J Exp Med 2002, 196(11):1507-1513.
42. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997, 388(6641):482-488.
43. Zwilling B.S., Kuhn D.E., Wikoff L., Brown D., Lafuse W. Role of iron in Nramp1-mediated inhibition of mycobacterial growth. Infect Immun 1999, 67(3):1386-1392.
44. Gomes M.S., Appelberg R. Evidence for a link between iron metabolism and Nramp1 gene function in innate resistance against Mycobacterium avium. Immunology 1998, 95(2):165-168.
45. Bowen H., Biggs T.E., Phillips E., Baker S.T., Perry V.H., Mann D.A., et al. c-Myc represses and Miz-1 activates the murine natural resistance-associated protein 1 promoter. J Biol Chem 2002, 277(38):34997-35006.